Jeong P - Search Results

1

Association of bladder tumors and GA genotype of -308 nucleotide in tumor necrosis factor-alpha promoter with greater tumor necrosis factor-alpha expression.

Jeong P, Kim EJ, Kim EG, Byun SS, Kim CS, Kim WJ. Jeong P, et al. Urology. 2004 Nov;64(5):1052-6. doi: 10.1016/j.urology.2004.06.018. Urology. 2004. PMID: 15533517

2

Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.

Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun Wee J, Kim WJ. Kim EJ, et al. Among authors: jeong p. Urology. 2005 Jan;65(1):70-5. doi: 10.1016/j.urology.2004.08.005. Urology. 2005. PMID: 15667866

3

RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.

Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, Yang JO, Ito Y, Bae SC. Kim WJ, et al. Among authors: jeong p. Cancer Res. 2005 Oct 15;65(20):9347-54. doi: 10.1158/0008-5472.CAN-05-1647. Cancer Res. 2005. PMID: 16230397

4

Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.

Kim EJ, Kim YJ, Jeong P, Ha YS, Bae SC, Kim WJ. Kim EJ, et al. Among authors: jeong p. J Urol. 2008 Sep;180(3):1141-5. doi: 10.1016/j.juro.2008.05.002. Epub 2008 Jul 18. J Urol. 2008. PMID: 18639281

5

Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.

Kim EJ, Lee YS, Kim YJ, Kim MJ, Ha YS, Jeong P, Lee OJ, Kim WJ. Kim EJ, et al. Among authors: jeong p. Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13. Urology. 2010. PMID: 19913893

6

Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: a novel approach using peptide nucleic acid-mediated, real-time PCR clamping.

Kim EJ, Yan C, Ha YS, Jeong P, Yi Kim I, Moon SK, Choi YH, Kim WJ. Kim EJ, et al. Among authors: jeong p. Urol Oncol. 2012 Sep;30(5):673-9. doi: 10.1016/j.urolonc.2010.07.008. Epub 2010 Sep 29. Urol Oncol. 2012. PMID: 20884250

7

Tumorigenic and prognostic significance of RASSF1A expression in low-grade (WHO grade 1 and grade 2) nonmuscle-invasive bladder cancer.

Ha YS, Jeong P, Kim JS, Kwon WA, Kim IY, Yun SJ, Kim GY, Choi YH, Moon SK, Kim WJ. Ha YS, et al. Among authors: jeong p. Urology. 2012 Jun;79(6):1411.e1-6. doi: 10.1016/j.urology.2012.01.042. Epub 2012 Mar 23. Urology. 2012. PMID: 22446336

8

Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis.

Jeong P, Ha YS, Yun SJ, Yoon HY, Freeman MR, Kim J, Kim WJ. Jeong P, et al. BMC Urol. 2015 Aug 7;15:80. doi: 10.1186/s12894-015-0074-x. BMC Urol. 2015. PMID: 26250800 Free PMC article.

9

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer.

Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS, Jeong P, Kim MJ, Yun SJ, Lee KM, Moon SK, Lee SC, Cha EJ, Bae SC. Kim WJ, et al. Among authors: jeong p. Mol Cancer. 2010 Jan 8;9:3. doi: 10.1186/1476-4598-9-3. Mol Cancer. 2010. PMID: 20059769 Free PMC article.

10

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.

Ha YS, Yan C, Lym MS, Jeong P, Kim WT, Kim YJ, Yun SJ, Lee SC, Moon SK, Choi YH, Kim WJ. Ha YS, et al. Among authors: jeong p. Dis Markers. 2010;29(2):81-7. doi: 10.3233/DMA-2010-0729. Dis Markers. 2010. PMID: 21045267 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters